bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small-cell lung cancer

By Koukourakis Michael   Giatromanolaki Alexandra   O’Byrne Keneth   Cox Jiles   Krammer Barbara   Gatter Kevin   Harris Adrian  

Clinical and Experimental Metastasis, Vol. 17, Iss. 7, 1999-09 ,pp. : 545-554

Springer Publishing Company

Access to resources Recommend Favorite

Overexpression of c-erbB2 protein correlates with disease-stage and chromosomal gain at the c-erbB2 locus in non-small cell lung cancer

By Kristiansen G.   Yu Y.   Petersen S.   Kaufmann O.   Schluns K.   Dietel M.   Petersen I.  

European Journal of Cancer, Vol. 37, Iss. 9, 2001-06 ,pp. : 1089-1095

Elsevier

Access to resources Recommend Favorite

The clinical relevance of Bcl-2, Rb and p53 expression in advanced non-small cell lung cancer

By Gregorc V.   Darwish S.   Ludovini V.   Pistola L.   De Angelis V.   Mihaylova Z.   Bellezza G.   Sidoni A.   Cavaliere A.   Bucciarelli E.   Massaro G.   Tonato M.  

Lung Cancer, Vol. 42, Iss. 3, 2003-12 ,pp. : 275-281

Elsevier

Access to resources Recommend Favorite

Clinical significance of the p53 pathway and associated gene therapy in non-small cell lung cancers

By Huang Cheng-long   Yokomise Hiroyasu   Miyatake Akira  

Future Oncology, Vol. 3, Iss. 1, 2007-02 ,pp. : 83-93

Future Medicine

Access to resources Recommend Favorite

Overexpression of c-erbB-2 and loss of p16 have molecular diagnostic relevance but no prognostic value in lung cancer

By Feng Xiao-li  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 336-341

Humana Press, Inc

Access to resources Recommend Favorite